Delivery Order SPE2DE24D0013-SPE2D626F24EG
- Not listed
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- On January 15, 2026, the Defense Logistics Agency Medical Supply Chain awarded a $20.4K delivery order (4570533435) to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2026, represents a child contract under Cepheid's larger Indefinite Delivery Contract framework with the Department of Veterans Affairs. The award carries no set-aside designation,...
- On December 24, 2025, the Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $7,480 for respiratory diagnostic testing supplies. The contract, designated XPCOV2/FLU/RSV-10, is scheduled for completion by January 9, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order is issued under an Indefinite Delivery Contract vehicle and requires no set-aside designation, reflecting Cepheid's...
- Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,099.70 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, represents procurement of diagnostic reagents and test kits—specifically XPRS4PLEX-10 cartridges designed for the GeneXpert diagnostic platform. The contract...
- This delivery order, issued December 19, 2025, by the Defense Logistics Agency Medical Supply Chain awards Cepheid Inc. a firm fixed-price contract valued at $1,277.84 for molecular diagnostic supplies and reagents. The contract has an ultimate completion date of December 29, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. As a leading federal supplier of advanced molecular diagnostic systems, Cepheid provides rapid infectious disease testing solutions including...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 delivery order to Cepheid Inc. on January 23, 2026, under a firm fixed-price contract with an ultimate completion date of January 30, 2026. This delivery order, identified as XPRS4PLEX-10, represents a child contract issued without a set-aside designation and is performed at Cepheid's facility in Sunnyvale, California. The award is part of Cepheid's ongoing relationship with the Department of Defense and federal healthcare...
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This is a child contract under a larger indefinite delivery vehicle, utilizing a firm fixed-price structure with no set-aside designation. The delivery order, identified as XPRSTREPA-10, pertains to diagnostic reagents and test kits for Cepheid's GeneXpert molecular...
- On January 20, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,240 to Cepheid Inc. for diagnostic reagents and test kits. This firm fixed-price delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 27, 2026, and represents performance work to be conducted at Cepheid's headquarters in Sunnyvale, California. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,720 by the Defense Logistics Agency Medical Supply Chain on December 17, 2025, with an ultimate completion date of December 24, 2025. This delivery order, designated XPRS4PLEX-10, is issued under an Indefinite Delivery Contract framework and carries no set-aside designation. The contract calls for the delivery of diagnostic reagents and test kits designed for Cepheid's GeneXpert...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F24EGDelivery Order
On January 23, 2026, the Defense Logistics Agency Medical Supply Chain awarded a $20,994.88 delivery order (Contract No. 4570623509, XPRS4PLEX-10) to Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California. This firm fixed-price delivery order, with an ultimate completion date of January 30, 2026, is a child contract under a larger indefinite delivery vehicle and carries no set-aside designation. The contract calls for the delivery of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform, specifically XPRS4PLEX-10 cartridges designed to detect multiple respiratory pathogens. Performance will occur at Cepheid's Sunnyvale facility. This delivery order reflects Cepheid's established role as a primary federal supplier of molecular diagnostic solutions across the Department of Defense health enterprise. Cepheid maintains extensive contracting relationships with multiple federal healthcare agencies, including the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and U.S. Coast Guard, delivering diagnostic equipment, reagents, test kits, and maintenance services. The company's GeneXpert platform has become a cornerstone technology for rapid infectious disease detection across federal healthcare systems, supporting testing for COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other conditions critical to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.0k | 1/22/26 |